SCHEMBL2817088

SCHEMBL2817088

CC(C)[Si](c1ccc2ccc(Br)cc2c1)(C(C)C)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.43
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
BACE1 P56817 2/20 0.36
LMNA P02545 2/20 0.33
RAB9A P51151 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
NOS1 P29475 2/20 0.32
METAP2 P50579 2/20 0.32
HTT P42858 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
CSNK2A1 P68400 1/20 0.32
DYRK1A Q13627 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259877 0.88 CYP1A2 (0.36) CYP2A6CYP1A2
SCHEMBL26259753 0.81 CYP1A2 (0.33) CYP2A6CYP1A2
SCHEMBL29901605 0.78 CYP2A6 (0.48) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL3825059 0.78 CYP2A6 (0.48) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL26259733 0.78 UGT2B7 (0.45) CYP2A6KDM4EMEN1ALDH1A1KMT2A
SCHEMBL1993021 0.77 CYP2A6 (0.42) CYP2A6ALDH1A1NOS1CYP1A2
SCHEMBL12277645 0.74 HPRT1 (0.32) ALDH1A1
SCHEMBL12260015 0.74 HPRT1 (0.32) ALDH1A1
SCHEMBL28477358 0.74 ALDH1A1 (0.43) ALDH1A1
SCHEMBL12405229 0.74 HPRT1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2235024-A1 NAPHTHYL-SUBSTITUTED ANTHRACENE DERIVATIVES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES SOLVAY (Société Anonyme) (BE) 2010-10-06 EP disclosed
US-20100244012-A1 Naphthyl-substituted anthracene derivatives and their use in organic light-emitting diodes SOLVAY (SOCIETE ANONYME) (BE) 2010-09-30 US disclosed
US-20100244012-A1 Naphthyl-substituted anthracene derivatives and their use in organic light-emitting diodes SOLVAY (SOCIETE ANONYME) (BE) 2010-09-30 US disclosed
EP-2107062-A1 Naphthyl-substituted anthracene derivatives and their use in organic light-emitting diodes SOLVAY (Société Anonyme) (BE) 2009-10-07 EP disclosed
WO-2009080716-A1 NAPHTHYL-SUBSTITUTED ANTHRACENE DERIVATIVES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES Solvay (Société Anonyme) (BE) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100244012-A1 Naphthyl-substituted anthracene derivatives and their use in organic light-emitting diodes CYBA, F12, LBR CYP2A6 681/4885KDM4E 3809/4885MEN1 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.